The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, June 18, 2018. All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, June 14, 2018. The preliminary changes, subject to modification, are summarized below.
LifeSci Biotechnology Clinical Trials Index
Additions (27 stocks):
ADAP, ADVM, ALBO, APLS, ARQL, ARWR, BHVN, CBIO, CCXI, CLSD, DCPH, DNLI, ECYT, FATE, MNOV, PGNX, RCKT, RCUS, RYTM, SELB, SGYP, SLDB, SRNE, SYRS, TORC, VKTX, VSTM
Deletions (11 stocks):
AGIO, ARDX, CALA, CLDX, DOVA, JNCE, MCRB, NLNK, RARE, RIGL, TTPH
Summary:
The updated index will have 98